These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 2124528)
1. Reactivities of antiphospholipid antibodies to blood cells and their effects on platelet aggregations in vitro. Ichikawa Y; Kobayashi N; Kawada T; Shimizu H; Moriuchi J; Ono H; Watanabe K; Arimori S Clin Exp Rheumatol; 1990; 8(5):461-8. PubMed ID: 2124528 [TBL] [Abstract][Full Text] [Related]
2. Platelet activation induced by combined effects of anticardiolipin and lupus anticoagulant IgG antibodies in patients with systemic lupus erythematosus--possible association with thrombotic and thrombocytopenic complications. Nojima J; Suehisa E; Kuratsune H; Machii T; Koike T; Kitani T; Kanakura Y; Amino N Thromb Haemost; 1999 Mar; 81(3):436-41. PubMed ID: 10102474 [TBL] [Abstract][Full Text] [Related]
3. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome. Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458 [TBL] [Abstract][Full Text] [Related]
4. [Association between antiphospholipid antibodies and arterial or venous thrombosis/thrombocytopenia]. Nojima J; Suehisa E; Kuratsune H; Amino N Rinsho Byori; 1998 Dec; 46(12):1181-7. PubMed ID: 9916502 [TBL] [Abstract][Full Text] [Related]
5. Anticardiolipin antibodies possess anticoagulant activity which is blocked by a monoclonal antibody against a cross reacting idiotype of antiphospholipid antibodies. Valesini G; Violi F; Ferro D; Quintarelli C; Falco M; Tincani A; Balestrieri G; Balsano F Clin Exp Rheumatol; 1989; 7(6):615-8. PubMed ID: 2515018 [TBL] [Abstract][Full Text] [Related]
6. Antiphospholipid antibodies and thrombosis in systemic lupus erythematosus: comparison of three lupus anticoagulant assays and anticardiolipin ELISA in 188 patients. Jouhikainen T; Julkunen H; Vaarala O; Leirisalo-Repo M; Stephansson E; Vahtera E; Palosuo T; Myllylä G Blood Coagul Fibrinolysis; 1992 Aug; 3(4):407-14. PubMed ID: 1420816 [TBL] [Abstract][Full Text] [Related]
7. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome. Arnout J Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685 [TBL] [Abstract][Full Text] [Related]
8. Binding specificity of lupus anticoagulants and anticardiolipin antibodies. McNeil HP; Chesterman CN; Krilis SA Thromb Res; 1988 Dec; 52(6):609-19. PubMed ID: 3148207 [TBL] [Abstract][Full Text] [Related]
9. Comparison of various screening and confirmatory tests for the detection of the lupus anticoagulant. Forastiero RR; Falcón CR; Carreras LO Haemostasis; 1990; 20(4):208-14. PubMed ID: 2122955 [TBL] [Abstract][Full Text] [Related]
10. Strong correlation between the prevalence of cerebral infarction and the presence of anti-cardiolipin/beta2-glycoprotein I and anti-phosphatidylserine/prothrombin antibodies--Co-existence of these antibodies enhances ADP-induced platelet activation in vitro. Nojima J; Kuratsune H; Suehisa E; Kitani T; Iwatani Y; Kanakura Y Thromb Haemost; 2004 May; 91(5):967-76. PubMed ID: 15116258 [TBL] [Abstract][Full Text] [Related]
11. Antiphospholipid antibodies: a disease marker in 25 patients with antinuclear antibody negative systemic lupus erythematosus (SLE). Comparison with a group of 91 patients with antinuclear antibody positive SLE. Meyer O; Piette JC; Bourgeois P; Fallas P; Bletry O; Jungers P; Kahn MF; Godeau P; Ryckewaert A J Rheumatol; 1987 Jun; 14(3):502-6. PubMed ID: 3114485 [TBL] [Abstract][Full Text] [Related]
12. [Lupus anticoagulants in patients with systemic lupus erythematosus]. Matsuura Y; Nawata Y; Miike S; Hiraguri M; Kita Y; Kurasawa K; Takabayashi K; Oh H; Iwamoto I; Saito Y Ryumachi; 1996 Feb; 36(1):16-24. PubMed ID: 8711533 [TBL] [Abstract][Full Text] [Related]
13. [The antiphospholipid syndrome in patients with systemic lupus erythematosus and in their closest blood relatives (a preliminary report)]. Sapsova E; Tsvetkova T; Ledzhev I; Terzieva D Vutr Boles; 1990; 29(5):96-9. PubMed ID: 2127871 [TBL] [Abstract][Full Text] [Related]
14. Beta 2-glycoprotein I is a requirement for anticardiolipin antibodies binding to activated platelets: differences with lupus anticoagulants. Shi W; Chong BH; Chesterman CN Blood; 1993 Mar; 81(5):1255-62. PubMed ID: 8443387 [TBL] [Abstract][Full Text] [Related]
15. Analysis of prothrombotic effects of two human monoclonal IgG antiphospholipid antibodies of apparently similar specificity. Lackner KJ; von Landenberg C; Barlage S; Schmitz G Thromb Haemost; 2000 Apr; 83(4):583-8. PubMed ID: 10780321 [TBL] [Abstract][Full Text] [Related]
16. Profile and cross-reactivities of antiphospholipid antibodies in systemic lupus erythematosus and syphilis. Meyer O; Cyna L; Bourgeois P; Kahn MF; Ryckewaert A Clin Rheumatol; 1987 Sep; 6(3):369-77. PubMed ID: 3127105 [TBL] [Abstract][Full Text] [Related]
17. Effect of plasma from patients with primary antiphospholipid syndrome on platelet function in a collagen rich perfusion system. Reverter JC; Tàssies D; Escolar G; Font J; López Soto A; Ingelmo M; Ordinas A Thromb Haemost; 1995 Jan; 73(1):132-7. PubMed ID: 7740485 [TBL] [Abstract][Full Text] [Related]
19. Studies on the relationship between 'antiphospholipid' antibodies and the lupus anticoagulant. Exner T; McRea J Blood Coagul Fibrinolysis; 1990; 1(1):17-21. PubMed ID: 2129389 [TBL] [Abstract][Full Text] [Related]
20. Anti-phospholipid antibodies in HIV infection and SLE with or without anti-phospholipid syndrome: comparisons of phospholipid specificity, avidity and reactivity with beta2-GPI. Petrovas C; Vlachoyiannopoulos PG; Kordossis T; Moutsopoulos HM J Autoimmun; 1999 Nov; 13(3):347-55. PubMed ID: 10550222 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]